GO:0160074 non-canonical inflammasome complex: Components, Assembly and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0160074 defines the non-canonical inflammasome complex, a cytosolic platform containing CASP4 (caspase-11 in mouse) that senses intracellular lipopolysaccharide (LPS).
• Unlike canonical inflammasomes, the non-canonical inflammasome directly binds LPS via CASP4/11 and activates Gasdermin-D (GSDMD) without requiring a sensor adaptor such as ASC.
• Activation of the non-canonical inflammasome triggers pyroptosis, a lytic inflammatory cell death, and release of IL-1 family cytokines.
• The complex is implicated in sepsis, inflammatory liver diseases, rheumatic diseases, silica-induced lung injury, and hereditary spastic paraplegia.
• Key protein components include CASP4 (human) / Casp11 (mouse), GSDMD, and upstream regulators such as guanylate-binding proteins (GBPs) and IRGB10.
• Research on GO:0160074 relies on CRISPR knockout, point-mutation, knock-in, and overexpression models combined with pyroptosis assays, cytokine profiling, and imaging.
Description
The non-canonical inflammasome complex (GO:0160074) is a cytosolic protein assembly that detects intracellular lipopolysaccharide (LPS) and initiates a rapid inflammatory cell death program. At its core, the complex contains CASP4 in humans and its ortholog caspase-11 (Casp11) in mice, which directly bind LPS and become activated without the need for a canonical sensor protein. This distinguishes it from canonical inflammasomes, which typically require NLRP3 or AIM2 sensors and the adaptor ASC to activate caspase-1. The non-canonical inflammasome is therefore a central node in innate immunity against Gram-negative bacteria and a driver of pathological inflammation when dysregulated. Researchers study GO:0160074 because it links cytosolic LPS sensing to Gasdermin-D (GSDMD) cleavage, pyroptosis, and the release of pro-inflammatory cytokines such as IL-1beta and IL-18. Its dysregulation has been associated with sepsis, inflammatory liver diseases, rheumatic conditions, silica-induced lung injury, and neurodegenerative disorders such as hereditary spastic paraplegia. Understanding the assembly, regulation, and downstream effects of this complex is essential for developing targeted anti-inflammatory therapies. This article provides a research-grade overview of GO:0160074, covering its definition, structure, molecular mechanism, key genes, disease relevance, and the experimental models used to study it. All statements are based on published literature and the QuickGO definition of the term.
non-canonical inflammasome complex At A Glance
| GO ID | GO:0160074 |
|---|---|
| GO term | non-canonical inflammasome complex |
| Ontology | cellular_component |
| Synonym | None listed in QuickGO |
| Major function | Cytosolic LPS sensing and direct activation of Gasdermin-D (GSDMD) leading to pyroptosis and inflammation |
| Core components | CASP4 (human) / Casp11 (mouse), GSDMD |
| Activation trigger | Cytosolic lipopolysaccharide (LPS) |
| Downstream effect | GSDMD cleavage, pyroptosis, IL-1beta/IL-18 release |
| Associated diseases | Sepsis, inflammatory liver diseases, rheumatic diseases, silica-induced lung injury, hereditary spastic paraplegia |
What Is GO:0160074?
According to the Gene Ontology, GO:0160074 (non-canonical inflammasome complex) is a cellular component defined as an inflammasome complex containing CASP4, known as caspase-11 (Casp11) in mouse, which assembles upon cytosolic lipopolysaccharide-binding and directly activates Gasdermin-D (GSDMD). In other words, it is a cytosolic multiprotein platform that senses intracellular LPS through CASP4/11 and triggers pyroptosis and inflammatory cytokine release without relying on canonical inflammasome sensors.
Why Is non-canonical inflammasome complex Important in Cell Biology?
GO:0160074 is important because it represents a non-canonical innate immune sensing pathway that directly detects cytosolic LPS and triggers pyroptosis, a highly inflammatory form of cell death. This pathway is critical for host defense against Gram-negative bacteria, but its excessive activation contributes to sepsis, inflammatory liver diseases, rheumatic diseases, and lung injury. Understanding the non-canonical inflammasome complex provides mechanistic insights into inflammatory diseases and offers potential targets for therapeutic intervention.
• Mediates cytosolic LPS sensing and direct activation of GSDMD, leading to pyroptosis.
• Plays a key role in innate immunity against Gram-negative bacterial infections.
• Contributes to sepsis pathogenesis through excessive inflammatory cell death.
• Implicated in inflammatory liver diseases, including non-alcoholic steatohepatitis and fulminant hepatitis.
• Associated with rheumatic diseases such as rheumatoid arthritis and gout.
• Involved in silica-induced lung injury and pulmonary inflammation.
• Linked to hereditary spastic paraplegia via hyperactivity in SPG11 and SPG48 mutations.
• Provides a target for anti-inflammatory drug development.
• Serves as a model for studying non-canonical inflammasome assembly and regulation.
• Enables research on crosstalk between pyroptosis and other cell death pathways.
What Happens During non-canonical inflammasome complex?
Cytosolic LPS Sensing
In simple terms: The complex detects LPS that has entered the cell cytosol.
The non-canonical inflammasome complex is activated when lipopolysaccharide (LPS) from Gram-negative bacteria gains access to the cytosol. CASP4 in humans and Casp11 in mice directly bind to the lipid A moiety of LPS, which triggers their oligomerization and activation. This sensing mechanism is independent of canonical inflammasome sensors such as NLRP3 or AIM2.
Complex Assembly and CASP4/11 Activation
In simple terms: CASP4 or caspase-11 molecules come together and become active enzymes.
Upon LPS binding, CASP4/Casp11 undergoes conformational changes that lead to its activation and assembly into a high-molecular-weight complex. This complex is considered the non-canonical inflammasome complex (GO:0160074). Activation requires upstream factors such as guanylate-binding proteins (GBPs) and IRGB10, which help liberate LPS from vacuolar bacteria into the cytosol.
Gasdermin-D Cleavage and Pyroptosis
In simple terms: Active CASP4/11 cuts GSDMD, which punches holes in the cell membrane and causes the cell to burst.
Activated CASP4/Casp11 cleaves Gasdermin-D (GSDMD) at a specific site, releasing its N-terminal pore-forming domain. The GSDMD N-terminal fragment inserts into the plasma membrane, forming pores that lead to osmotic lysis and pyroptosis. This lytic cell death releases pro-inflammatory contents, including IL-1beta and IL-18, amplifying inflammation.
Cytokine Release and Inflammatory Amplification
In simple terms: Cell bursting releases inflammatory signals that call immune cells to the site.
Pyroptosis mediated by the non-canonical inflammasome complex results in the release of IL-1beta and IL-18, which are processed by caspase-1 activated downstream of GSDMD pores or by other mechanisms. These cytokines recruit immune cells and amplify the inflammatory response. This pathway is a major contributor to cytokine storm in sepsis and other inflammatory conditions.
Regulation by GBPs and Other Host Factors
In simple terms: Other proteins help or restrain the complex to keep it under control.
Guanylate-binding proteins (GBPs) and IRGB10 promote cytosolic release of LPS and facilitate CASP4/11 activation. Conversely, negative regulators such as autophagy proteins and certain ubiquitin ligases can limit inflammasome activity to prevent excessive inflammation. The balance between activation and inhibition determines the extent of pyroptosis and tissue damage.
Key Genes Involved in GO:0160074 non-canonical inflammasome complex
The following genes and proteins are central to the assembly, regulation, and function of the non-canonical inflammasome complex (GO:0160074).
| Gene | Major Role | Research Relevance |
|---|---|---|
| CASP4 | Human caspase-4; directly binds cytosolic LPS and activates GSDMD | Core component of GO:0160074; knockout and point-mutation studies |
| CASP11 (mouse) | Mouse caspase-11; ortholog of CASP4; binds LPS and cleaves GSDMD | Mouse models of sepsis and inflammation |
| GSDMD | Gasdermin-D; pore-forming effector of pyroptosis downstream of CASP4/11 | Knockout models to block pyroptosis |
| GBP1 | Guanylate-binding protein 1; promotes cytosolic LPS release | Regulator of inflammasome activation |
| GBP2 | Guanylate-binding protein 2; facilitates CASP4/11 activation | Host defense against Gram-negative bacteria |
| GBP3 | Guanylate-binding protein 3; involved in LPS sensing | Modulates inflammasome assembly |
| GBP4 | Guanylate-binding protein 4; contributes to cytosolic LPS detection | Regulatory node in non-canonical inflammasome |
| GBP5 | Guanylate-binding protein 5; promotes CASP4/11 activation | Genetic studies of inflammasome regulation |
| IRGB10 | Interferon-inducible GTPase; helps liberate LPS from bacteria | Upstream regulator of non-canonical inflammasome |
| IL1B | Interleukin-1 beta; pro-inflammatory cytokine released during pyroptosis | Cytokine readout in inflammasome studies |
| IL18 | Interleukin-18; pro-inflammatory cytokine released during pyroptosis | Biomarker of inflammasome activation |
| NLRP3 | Canonical inflammasome sensor; crosstalk with non-canonical pathway | Comparative studies of canonical vs non-canonical inflammasomes |
| AIM2 | Canonical inflammasome sensor; not required for non-canonical complex | Distinguishing canonical and non-canonical pathways |
| ASC (PYCARD) | Adaptor for canonical inflammasomes; dispensable for non-canonical complex | Genetic dissection of inflammasome signaling |
| SPG11 | Spastic paraplegia gene; mutations cause non-canonical inflammasome hyperactivity | Disease model for hereditary spastic paraplegia |
| SPG48 | Spastic paraplegia gene; mutations linked to inflammasome hyperactivity | Disease model for hereditary spastic paraplegia |
| CASP1 | Canonical inflammasome caspase; activated downstream of GSDMD pores | Crosstalk between canonical and non-canonical pathways |
How Is non-canonical inflammasome complex Regulated?
The non-canonical inflammasome complex is regulated at multiple levels. Upstream, guanylate-binding proteins (GBPs) and IRGB10 promote cytosolic release of LPS and facilitate CASP4/11 activation. Interferon signaling enhances expression of GBPs and CASP4/11, priming the pathway. Negative regulation occurs through autophagy, which can degrade inflammasome components, and through ubiquitination and degradation of CASP4/11. Additionally, GSDMD pore formation is controlled by membrane repair mechanisms and by the availability of GSDMD. Dysregulation of these regulatory layers contributes to inflammatory diseases.
non-canonical inflammasome complex and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| CASP4 | Sepsis, inflammatory liver disease | CASP4 knockout mice or human cell lines |
| CASP11 | Sepsis, rheumatic diseases | Casp11 knockout mice |
| GSDMD | Pyroptosis-related inflammatory diseases | Gsdmd knockout mice |
| SPG11 | Hereditary spastic paraplegia | SPG11 mutant knock-in or knockout models |
| SPG48 | Hereditary spastic paraplegia | SPG48 mutant knock-in or knockout models |
Sepsis and Inflammatory Liver Diseases
The non-canonical inflammasome complex is a major driver of sepsis pathogenesis, where excessive CASP4/11 activation and GSDMD-mediated pyroptosis lead to cytokine storm and multi-organ failure. In inflammatory liver diseases, including non-alcoholic steatohepatitis and fulminant hepatitis, caspase-11 activation contributes to hepatocyte pyroptosis and liver damage. Targeting this pathway is being explored as a therapeutic strategy for these conditions.
Rheumatic Diseases
Caspase-11 non-canonical inflammasome activity has been implicated in rheumatic diseases such as rheumatoid arthritis and gout. In these conditions, cytosolic LPS or endogenous danger signals can trigger CASP4/11 activation, leading to IL-1beta release and joint inflammation. Understanding the role of GO:0160074 in rheumatic diseases may inform new anti-inflammatory treatments.
Neurodegeneration and Hereditary Spastic Paraplegia
Mutations in SPG11 and SPG48 cause hereditary spastic paraplegia and are associated with hyperactivity of the non-canonical inflammasome. This hyperactivity leads to increased pyroptosis and neuroinflammation, contributing to motor neuron degeneration. The non-canonical inflammasome complex is therefore a potential therapeutic target in these neurodegenerative disorders.
Lung Injury and Environmental Exposure
Silica exposure activates the non-canonical inflammasome complex in rat models, leading to pulmonary inflammation and injury. This suggests that environmental particulates can trigger CASP4/11-dependent pyroptosis in the lung. Studying GO:0160074 in this context may reveal mechanisms of occupational lung diseases.
From non-canonical inflammasome complex-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does CASP4 mediate cytosolic LPS sensing? | CASP4 knockout human macrophages or epithelial cells |
| Is Casp11 required for sepsis-induced pyroptosis? | Casp11 knockout mice in LPS-induced sepsis models |
| Does a specific point mutation in CASP4 affect LPS binding? | CASP4 point-mutation knock-in cell lines |
| Can GSDMD cleavage be monitored in real time? | GSDMD-tagged knock-in reporter cells |
| Does overexpression of GBP1 enhance inflammasome activation? | GBP1 overexpression cell lines |
| Is SPG11 mutation sufficient to cause inflammasome hyperactivity? | SPG11 mutant knock-in or knockout neurons |
How to Study the non-canonical inflammasome complex Process
| Method | What It Measures | Typical Application |
|---|---|---|
| LDH release assay | Membrane permeabilization and pyroptosis | Quantifying cell death after LPS transfection |
| IL-1beta ELISA | Cytokine release | Measuring inflammasome activation in cell supernatants |
| Immunoblotting | CASP4/11 cleavage and GSDMD processing | Confirming inflammasome activation |
| Fluorescence microscopy | CASP4/11 oligomerization and GSDMD pores | Visualizing complex assembly |
| Proteomics | Protein interactions and modifications | Identifying novel regulators |
| CRISPR knockout screening | Gene requirement for pyroptosis | Discovering essential inflammasome components |
| RNA-seq | Transcriptional changes during inflammasome activation | Mapping inflammatory gene expression |
| Flow cytometry | Cell death and cytokine production at single-cell level | Analyzing heterogeneous responses |
Pyroptosis Assays
Pyroptosis is commonly measured by lactate dehydrogenase (LDH) release, propidium iodide uptake, or Caspase-Glo assays. These assays quantify membrane permeabilization and cell death following non-canonical inflammasome activation. They are used to assess the functional impact of genetic perturbations in CASP4, Casp11, or GSDMD.
Cytokine Profiling
IL-1beta and IL-18 release are measured by ELISA or multiplex cytokine arrays to assess inflammasome activation. These readouts are used in cell culture and animal models to quantify inflammatory responses. They help distinguish non-canonical from canonical inflammasome activation.
Imaging and Microscopy
Fluorescence microscopy and live-cell imaging are used to visualize CASP4/11 oligomerization, GSDMD pore formation, and membrane rupture. Tagged knock-in cell lines expressing fluorescently labeled CASP4 or GSDMD enable real-time monitoring of complex assembly. These methods provide spatial and temporal resolution of inflammasome activation.
Proteomics and Immunoblotting
Immunoblotting for CASP4/11 cleavage and GSDMD N-terminal fragment generation is standard for confirming inflammasome activation. Proteomic approaches can identify interacting partners and post-translational modifications of the complex. These methods are essential for mechanistic studies of GO:0160074.
How CRISPR Can Be Used to Study GO:0160074 non-canonical inflammasome complex
Knockout
CRISPR knockout of CASP4, Casp11, or GSDMD is used to abolish non-canonical inflammasome function and confirm their essential roles in LPS-induced pyroptosis. Knockout cell lines and mice are standard tools for studying GO:0160074. These models help distinguish non-canonical from canonical inflammasome pathways.
Point Mutation
Point mutations in CASP4 or Casp11 can be introduced to dissect catalytic activity, LPS-binding residues, or cleavage sites. Such models allow precise structure-function analysis of the non-canonical inflammasome complex. They are valuable for understanding how specific residues contribute to activation and substrate recognition.
Knock-in
Knock-in of tagged CASP4, Casp11, or GSDMD (e.g., fluorescent or epitope tags) enables real-time tracking of complex assembly and localization. Knock-in models can also introduce disease-associated mutations, such as those in SPG11 or SPG48, to study inflammasome hyperactivity. These models are essential for translational research on GO:0160074.
Overexpression
Overexpression of CASP4, Casp11, GBPs, or GSDMD is used to amplify inflammasome signaling and study downstream effects. Overexpression systems help identify sufficiency of individual components in triggering pyroptosis. They are also used in screening assays to test inhibitors of the non-canonical inflammasome.
How EDITGENE Supports non-canonical inflammasome complex Research
Researchers studying non-canonical inflammasome complex-related genes often need to determine whether a candidate gene is causally involved in cytosolic LPS sensing, GSDMD activation, or pyroptosis. EDITGENE provides CRISPR-based cell model services to enable such causal studies with precision and reproducibility.
Contact EDITGENE today to design your custom CRISPR model for non-canonical inflammasome complex research.
Frequently Asked Questions About non-canonical inflammasome complex
What is the non-canonical inflammasome complex?
The non-canonical inflammasome complex (GO:0160074) is a cytosolic protein assembly containing CASP4 (caspase-11 in mouse) that senses intracellular LPS and directly activates Gasdermin-D to trigger pyroptosis.
What genes are involved in the non-canonical inflammasome complex?
Key genes include CASP4, CASP11 (mouse), GSDMD, GBPs, IRGB10, and disease-associated genes such as SPG11 and SPG48.
How does the non-canonical inflammasome differ from the canonical inflammasome?
The non-canonical inflammasome directly binds cytosolic LPS via CASP4/11 and does not require canonical sensors like NLRP3 or the adaptor ASC, whereas canonical inflammasomes rely on sensor-ASC-caspase-1 platforms.
What is the role of CASP4 in the non-canonical inflammasome?
CASP4 is the core sensor and effector of the human non-canonical inflammasome; it binds LPS, oligomerizes, and cleaves GSDMD to induce pyroptosis.
What diseases are associated with the non-canonical inflammasome complex?
It is implicated in sepsis, inflammatory liver diseases, rheumatic diseases, silica-induced lung injury, and hereditary spastic paraplegia.
How is the non-canonical inflammasome activated?
It is activated when cytosolic LPS binds CASP4/11, often facilitated by GBPs and IRGB10, leading to CASP4/11 oligomerization and GSDMD cleavage.
What is the role of GSDMD in the non-canonical inflammasome pathway?
GSDMD is the downstream effector; once cleaved by CASP4/11, its N-terminal fragment forms pores in the plasma membrane, causing pyroptosis and cytokine release.
Can CRISPR be used to study the non-canonical inflammasome complex?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models are widely used to dissect the roles of CASP4, Casp11, GSDMD, and regulators in this complex.
What experimental models are used to study GO:0160074?
Common models include CASP4 or Casp11 knockout mice and cell lines, GSDMD knockout cells, tagged knock-in reporters, and overexpression systems.
Why is the non-canonical inflammasome important for inflammation?
It triggers pyroptosis and release of IL-1beta and IL-18, which are potent inflammatory mediators; dysregulation leads to cytokine storm and tissue damage.
Conclusion
The non-canonical inflammasome complex (GO:0160074) is a critical cytosolic LPS-sensing platform that directly activates GSDMD and drives pyroptosis. Its core components CASP4 and caspase-11 are essential for host defense but also contribute to inflammatory diseases such as sepsis, liver disease, rheumatic conditions, and neurodegeneration. Understanding its assembly, regulation, and downstream effects is vital for developing targeted therapies. CRISPR-based models, including knockout, point mutation, knock-in, and overexpression, are indispensable for mechanistic studies of GO:0160074. EDITGENE provides comprehensive services to accelerate this research and enable precise causal interrogation of non-canonical inflammasome biology.
References
- 1. Downs KP et al.. 2020. An overview of the non-canonical inflammasome.. Mol Aspects Med 76:100924 PMID: 33187725
- 2. Triantafilou K. 2021. Enigmatic inflammasomes.. Immunology 162(3):249-251 PMID: 33590488
- 3. Liu Y et al.. 2024. Pyroptosis in health and disease: mechanisms, regulation and clinical perspective.. Signal Transduct Target Ther 9(1):245 PMID: 39300122
- 4. Afzal MA et al.. 2025. Hyperactivity of the non-canonical inflammasome in SPG11 and SPG48.. EBioMedicine 121:105985 PMID: 41138668
- 5. Yi YS. 2024. Roles of the Caspase-11 Non-Canonical Inflammasome in Rheumatic Diseases.. Int J Mol Sci 25(4) PMID: 38396768
- 6. Yi YS. 2022. Regulatory Roles of Caspase-11 Non-Canonical Inflammasome in Inflammatory Liver Diseases.. Int J Mol Sci 23(9) PMID: 35563377
- 7. Niu Y et al.. 2022. Silica exposure activates non-canonical inflammasome complex in intratracheal instilled rat model.. Toxicol Res (Camb) 11(5):784-790 PMID: 36337236
- 8. Pandey A et al.. 2025. Molecular mechanisms of emerging inflammasome complexes and their activation and signaling in inflammation and pyroptosis.. Immunol Rev 329(1):e13406 PMID: 39351983
